ARCHIVES

Research teams link response to Iressa to mutations in EGF receptor.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

April 28, 1978